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ABSTRACT 
Exploring the Effects of Gut-derived Microbial Metabolites on Expression of SPI-1 Genes and 
Antimicrobial Resistance in Salmonella typhimurium. (May 2014) 
 
Rebekah Elizabeth Davis 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Robert C. Alaniz 
Department of Microbial Pathogenesis and Immunology 
Texas A&M College of Medicine 
 
The commensal bacteria that naturally inhabit the human gut are known to be beneficial to the 
host in a variety of ways, including producing compounds, such as indole and tryptamine, that 
reduce the invasion and colonization capability of enteric pathogens, such as Salmonella enterica 
serovar Typhimurium.  Here we explore the effects of other tryptophan metabolites on the 
expression of genes that S. typhimurium uses for invasion into host cells: the Salmonella 
Pathogenicity Island-1 (SPI-1) genes.  We also test whether smaller dosages of one tryptophan 
metabolite, indole, confers antimicrobial resistance to S. typhimurium (thereby benefiting the 
pathogen rather than the host), through upregulation of the SPI-2 genes and subsequent outer 
membrane modification.        
  
 2 
 
DEDICATION 
 
This paper is dedicated to my wonderful, lively, happy son, Daegan, who always provides me 
necessary comic relief during stressful times and to my very supportive partner, Marc, who is my 
rock.  This research would not have been possible without their support.  
 3 
 
ACKNOWLEDGEMENTS 
 
I must acknowledge the mentoring I received from Zeni Crisp, who put up with my silly rookie 
questions patiently.  I must also thank Dr. Robert C. Alaniz for allowing me to engage in this 
research in the first place (when he really did not have to) and for inspiring creativity and 
encouraging deep thinking in my mind.  I also must thank the other people in the Alaniz lab who 
were kind and answered my questions patiently: Carrie Mueller, Madhu Katepalli, Shelby 
Steinmeyer, and Jane Miller as well as our collaborators, Dr. Arul Jayaraman and Nandita Kohli.  
  
 4 
 
CHAPTER I 
INTRODUCTION 
 
Salmonella enterica serovar Typhimurium, the bacterium that causes nontyphoidal 
salmonellosis, is a growing cause for concern.  This is due to the fact that 1) it causes over a 
million cases of nontyphoidal salmonellosis in the U.S. per year;
1
 2) it is the leading cause of 
mortality in cases of food-borne illness;
2
 3) it is especially fatal in developing countries and in 
certain populations, including the immunocompromised;
3
 and 4) the number of cases of infection 
with multi-drug resistant salmonella has increased in recent years.
4  
Further investigation into the 
host-microbe interactions is warranted.  This is to be accomplished by analyzing the effects of 
commensal microbial metabolites on the expression of certain genes in S. typhimurium, as well 
as analyzing the effects of the host’s commensal gut bacteria on invading S. typhimurium.  The 
expected result of these endeavors is to increase the body of knowledge related to this subject in 
order to develop better means of treating nontyphoidal salmonellosis. 
 
Salmonella typhimurium causes approximately 1.4 million cases of nontyphoidal salmonellosis 
in the U.S. alone
1
 and approximately 93.8 million cases worldwide
5
.  Of these, roughly 155,000 
(with a 95% Confidence Interval of 39,000 – 303,000) are fatal5.  S. typhimurium is known to be 
especially fatal for children under five years of age (in the U.S.)
5
, those who are malnourished
6
, 
and those with compromised immune systems
6
.  For example, in Sub-Saharan Africa, the 
pathogen has a mortality rate up to 45%, which is now suspected to be associated with the 
compromised immune systems of those with comorbid HIV or Plasmodium spp. infections
6
.  
Regarding this epidemic in Africa, the majority of infections with S. typhimurium are ones that 
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exhibit multidrug-resitantance
7
, which is also a growing cause for concern in developed 
countries due to the very nature of the mechanisms of antibiotic resistance in bacteria in general.  
While infection with S. typhimurium is a very serious public health issue in developing countries, 
it also causes 31% of mortalities associated with food-borne illness in the United States
2
.  In 
addition, S. typhimurium is also a potential bioterrorism agent: in 1984, the Rajneesh cult seeded 
the salad bars of several restaurants in Oregon with the bacterium, resulting in 751 people 
contracting the illness
8
.   
 
Steps have been taken by researchers to better understand host-microbe interactions in order to 
help alleviate these current problems, but much more is needed.  It has been discovered that S. 
typhimurium can modulate the host immune system in a variety of ways:  according to Alaniz et 
al., one way S. typhimurium avoids the host’s immune system is to regulate the production and 
location of the protein that the bacterium uses to form its flagella, FliC, which makes the protein 
then unavailable to dendritic cells.
9
   It has also been discovered that metabolites produced by the 
host commensal gut bacteria can have effects on invading pathogens: Alaniz et al. found that a 
metabolite produced by the host’s gut bacteria, indole, induces dendritic cell antimicrobial 
activity and reduces the invasion capability of the bacterium (perhaps by reducing the expression 
of SPI-1 genes) concurrent with increased intracellular replication and survival (possibly through 
a small upregulation in the SPI-2 genes) (Crisp Z, Kohli N, Mueller C, Jayaraman A, Alaniz RC., 
unpublished data).   While these results are very promising, more investigation is needed. 
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CHAPTER II 
METHODS 
 
Minimum Inhibitory Concentrations  
Minimum Inhibitory Concentrations (MICs) were performed according to the Agar Dilution 
Method protocol developed by the NCCLS, with the exception that no spot-inoculator was used.  
A known concentration of bacteria was inoculated onto the agar using a spreader kit in the place 
of the spot-inoculator. 
 
SPI-1 Reporter Assays 
The reporter strains used contain hilA, invF, or prgH genes from the Salmonella Pathogenicity 
Island (SPI-1) joined to the lacZ gene from Escherichia coli, which produces ß-galactosidase.  
The agar on which the particular strain of S. typhimurium was grown is made selective by being 
provided with a substrate (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside or X-Gal) that 
produces a blue color when cleaved by ß-galactosidase.  The genes used are also contained on a 
resistance plasmid and grown in the presence of Tetracycline to maintain selectivity for the gene.  
Resorufin ß-D-galactopyranoside (Res-Gal) is also a substrate for ß-galactosidase that fluoresces; 
the amount of fluorescence was measured using a plate reader.   
The particular S. typhimurium strain used was grown for 16 hours at 37°C and 110 rpm with 
aeration in 10 mLs Luria-Bertani (LB) broth with a tryptophan metabolite or negative (solvent) 
control.  The culture was then back-diluted to 1:32.  This back-diluted culture was then 
inoculated into a 96-well plate with 200 µLs per well in triplicate for each condition: wild-type 
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with no treatment, solvent control, and titrated doses of the tryptophan metabolite.  Conditions 
for fluorescence were then added: 5.0 µg/mL Res-Gal to each well or DMSO as a solvent 
control.  Fluorescence was then measured at 544 nm excitation and 590 nm emission and 
absorbance at 600 nm for optical density of bacteria to visualize bacteria going into log phase 
every half hour for three hours.  The plate was kept in an incubator at 37°C in between 
measurements.  The measurements were then placed into graphical form using GraphPad Prism 5 
software. 
 
Antimicrobial Resistance Assays 
Wild-type S. typhimurium +/- 100-25µM indole (+ 0.005% DMF as negative control) were 
grown in 10 mLs LB broth at 37°C and 110 rpm with aeration for 22 hours, as consistent 
CFU/mL are obtained at this time point.  The cultures were then back-diluted 1:100 in LB broth 
and grown for three hours at 37°C and 110 rpm with aeration to achieve log phase.  Each culture 
condition was then plated at the 10
-5
 dilution in triplicate on LB agar and incubated overnight at 
37°C and 5% CO2.  The antibiotic (10X MIC or 5X MIC for Ampicillin) was then added to each 
condition and incubated for 4 hours at 37°C and 110 rpm with aeration to allow killing of all 
sensitive cells.  Each culture condition was then plated at 10
-3
 dilution in triplicated and 
incubated overnight at 37°C and 5% CO2 .  CFU/mL was then determined for both the pre-
antibiotic treatment and post-antibiotic treatment cultures.  CFU/mL before Ampicillin treatment 
was divided by CFU/mL after Ampicillin treatment to quantify bacterial survival; these values 
were then entered into graphical form using GraphPad Prism 5 software. 
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CHAPTER III 
RESULTS 
 
The effects of the tryptophan metabolite tryptamine on SPI-1 genes hilA, prgH, and invF were 
tested using the SPI-1 reporter assay.  The effects of the tryptophan metabolites 5-hydroxyindole 
and indole-3-carbinol were tested on SPI-1 gene hilA; this gene was chosen as the main gene to 
test since it encodes the main transcription regulator of the other SPI-1 genes.  Indole was used 
as a positive control in each of these experiments, since it has already been established that 
indole suppresses the expression of SPI-1 genes
10
 .  Tryptamine did not appear to have any 
significant effect on the expression of the SPI-1 genes hilA, prgH, or invF (Figure 1); 5-
hydroxyindole did not appear to have any significant effect on the expression of hilA (Figure 2).  
However, indole-3-carbinol did appear to suppress the expression of hilA (Figure 2), though not 
to the same extent that indole does.  It should be noted that indole-3-carbinol is not a microbial 
metabolite but is instead found in cruciferous vegetables.
 9 
 
 
 
 
 
 
The effects of indole on antimicrobial resistance in this bacterium was assesed using the 
antimicrobial resistance assay described above.  Micromolar amounts of indole appear to confer 
antimicrobial resistance on S. typhimurium when treated with both Ampicillin (Figures 3 and 4) 
and Polymyxin B (Figures 5 and 6).    Ampicillin was chosen because 1) it is clinically relevant 
Figure 1.  Effects of different doses of tryptamine on S. typhimurium SPI-1 genes hilA, prgH, and invF, 
respectively. 
Figure 2.  Effects of different doses of 5-hydroxyindole and indole-3-carbinol on S. typhimurium SPI-1 gene 
hilA, respectively. 
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and 2) it attacks the core polysaccharide of lipopolysaccharide (LPS) to gain ingress to the 
bacterium to prevent the transpeptidase reaction.  
 
 
 
 
 
 
Figure 3. Fold survival of WT S. typhimurium and different dosages of indole after 100µg and 150µg Ampicillin, 
respectively. 
Figure 4.  Representative pictures of S. typhimurium incubated with varying amounts of indole + DMF negative 
control then treated with Ampicillin. 
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Polymxyin B was chosen because it creates pores in the outer membrane of the bacterium by 
attacking the lipid A portion of LPS, thus destabilizing the outer membrane and causing lysis.     
Since both of these antibiotics  act on the outer membran of the bacterium, the mechanism of this 
resistance may be through modification of the outer membrane by the bacterium. 
 
 
 
 
 
Figure 5. Fold survival of WT S. typhimurium and different dosages of indole after 1.563µg and 1.600µg  Polymyxin B, 
respectively. 
 
Figure 6.  Representative pictures of S. typhimurium incubated with varying amounts of indole + DMF negative 
control then treated with Polymyxin B. 
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CHAPTER IV 
DISCUSSION 
 
These data suggest that indole, in millimolar amounts, reduces SPI-1 genes, and subsequently 
invasion by the bacterium, the most effectively as compared to other tryptophan metabolites.  
This benefits the human host.  However, these data also suggest that indole, in micromolar 
amounts, confers antimicrobial resistance on the bacterium, benefiting the pathogen.  These 
conclusions demonstrate the complex relationships that can evolve between the host, its 
commensal symbiotic bacteria, and invading pathogens.  The reduction in the SPI-1 genes 
(which encode a type III secretion system (T3SS) that facilitates invasion into host cells, 
including formation of a “needle complex” to mechanically gain entry into the host cell) by 
indole has been supported by functional assays using HeLa and DC 2.4 cells (Crisp Z, Kohli N, 
Mueller C, Jayaraman A, Alaniz RC, unpublished data).  This antimicrobial resistance mediated 
by indole is hypothesized to be caused by an upregulation in the SPI-2 genes, which is the type 
III secretion system (T3SS) that is used by the bacterium when located intracellularly in a host 
cell.  These genes facilitate survival and replication of the bacterium while in this hostile 
environment: one of these functions is to extensively modify the outer membrane.  This would be 
consistent with previously discovered data (Crisp Z, Kohli N, Mueller C, Jayaraman A, Alaniz 
RC, unpublished data).  Since it is hypothesized that this antimicrobial resistance is mediated 
through a modification in the outer membrane of the bacterium, it would be interesting to assess 
the effects of micromolar amounts of indole treatment on S. typhimurium treated with antibiotics 
that target other parts of the cell.   
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APPENDIX A 
NEGATIVE CONTROLS AND GROWTH CURVES FOR REPORTER 
ASSAYS 
 
Negative controls were generated for each of the SPI-1 Reporter Assays by running a solvent 
control for Res-Gal, DMSO, alongside the fluorescent compound in triplicate.  The solvent 
control is the only difference in this case.  Graphs were generated for each experiment based 
upon the same scale as the experimental data using Res-Gal.  In addition, growth curves were 
generated for each experiment to ensure that the bacteria properly entered log phase and that they 
were growing as expected.  As explained above, this was measured by taking the absorbance of 
the sample at 600nm at regular intervals (the same intervals in which the fluorescence was 
measure for the effect on the SPI-1 genes) using a plate reader.  Graphs were generated for these 
data as well, and can be seen alongside the negative control data in Figures 7-11 for each 
experiment in numerical order. 
 
 
 
 
Figure 7.  Growth curve and negative control data, respectively, for Experiment 32: effect of different doses 
of tryptamine on S. typhimurium SPI-1 gene hilA. 
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Figure 8.  Growth curve and negative control data, respectively, for Experiment 34: effect of different doses 
of tryptamine on S. typhimurium SPI-1 gene prgH. 
Figure 9.  Growth curve and negative control data, respectively, for Experiment 36: effect of different doses 
of tryptamine on S. typhimurium SPI-1 gene invF. 
Figure 10.  Growth curve and negative control data, respectively, for Experiment 42: effect of different doses 
of 5-hydroxyindole on S. typhimurium SPI-1 gene hilA. 
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Figure 11.  Growth curve and negative control data, respectively, for Experiment 43: effect of different doses 
of indole-3-carbinol on S. typhimurium SPI-1 gene hilA. 
